August 2019 FDA Recall Drug by Epi Health, Llc
D-0120-2020 - Failed Dissolution Specifications
This Class III drug recall was voluntarily initiated by Epi Health, Llc on August 26, 2019 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed in Firm recalling only from EPI Field Representatives. and the recall is currently terminated.
Recall Number: D-0120-2020
Failed Dissolution Specifications:
08-26-2019
10-02-2019
1,626 5-count bottles
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
EPI Health, LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Firm recalling only from EPI Field Representatives.
08-18-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets, Rx Only, Mfg by: Dr. Reddy's Laboratories Limited, FTO-SEZ, Process Unit-01 Devunipalavalasa Village Srikakulam (District) Andhra Pradesh, INDIA. Manufactured for: EPI Health, LLC 134 Columbus St. Charleston, SC 29403 USA. NDC 71403-102-05.
Batch or Lot Expiration Information
Lot# T900093, Exp 11/2020